DAVID FARROW: Open Payments
NPI 1417518564 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,292 in 98 payments from 27 companies in 2025. Trend: 2023 $1,700 · 2024 $1,887 · 2025 $2,292
Food & beverage: $2,292
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $357 |
| AstraZeneca Pharmaceuticals LP | 7 | $235 |
| ViiV Healthcare Company | 8 | $218 |
| Boston Scientific Corporation | 3 | $160 |
| Aimmune Therapeutics, Inc. | 5 | $130 |
| Sumitomo Pharma America, Inc. | 4 | $108 |
| Gilead Sciences, Inc. | 5 | $102 |
| Merck Sharp & Dohme LLC | 5 | $101 |
| Corcept Therapeutics | 3 | $89 |
| ABBVIE INC. | 4 | $86 |
Products named: DOVATO, BREZTRI, ZENPEP, WATCHMAN FLX, Ozempic, GEMTESA, JARDIANCE, PIFELTRO.
Industry payments across AZ — which companies pay providers there.
